
Should your clinic carry the CJC-1295 plus Ipamorelin blend, plain Sermorelin, or both? It is one of the most common questions we hear from weight loss and wellness clinics, usually after a patient or a sales rep has already muddied the water. What owners really want is a straight, honest answer, not a pitch.
So think of this as the CJC-1295 and Ipamorelin vs Sermorelin conversation with someone who coordinates this for a living. This is not medical advice. It is background so you can ask better questions and make calmer decisions.
First, what these products actually are
All three sit in a family called growth hormone secretagogues, a category our clinic guide to growth hormone secretagogue peptides walks through end to end. That is a long name for a simple idea. Instead of putting growth hormone into the body directly, the way something like Somatropin does, these products nudge the body’s own pituitary gland to release a bit more of its own growth hormone. It is the difference between handing someone a coffee and gently tapping them on the shoulder so they go make their own. That distinction matters, and we will come back to it, because patients mix these up constantly.
Sermorelin is the old-timer here. It is a synthetic peptide built from the first 29 amino acids of natural growth hormone releasing hormone, which is the active piece of that signal. It talks to the pituitary through one door, the GHRH pathway. Here is the part most people do not know. The FDA actually approved Sermorelin back in 1997 under the name Geref, and its maker pulled it from the market in 2008 for business reasons, not because anyone found it unsafe. The FDA later confirmed that point. Today it lives on mainly through compounding pharmacies, and it is the Sermorelin 10 mg injection a lot of clinics still keep on the shelf.
Where CJC-1295 and Ipamorelin fit in
CJC-1295 works on that same GHRH door, so in a sense it is Sermorelin’s younger cousin. The difference is that chemists engineered it to hang around in the body much longer.
Ipamorelin is the odd one out, and in a good way. It is a small peptide that copies ghrelin, your hunger and rhythm hormone, and it knocks on a completely different door called the ghrelin receptor. Researchers call it selective, which is a nice quality. In plain terms, it tends to stay in its lane and nudge growth hormone without stirring up other hormones like cortisol as much.
Now the reason the blend exists. Sermorelin uses one door. The CJC-1295 plus Ipamorelin combination uses two doors at once, a GHRH signal and a ghrelin signal working together. Research going back to the late 1990s showed that pushing on both pathways at the same time can produce a bigger, more natural pulse of growth hormone than either one alone. That is the whole idea behind pairing them into a single product.
The differences that actually change your decision
Let me put the useful stuff in one place. This is a purchasing and menu view, not a dosing chart. How anything is actually used belongs with a licensed prescriber and the current rules in your state.
| What you are weighing | Sermorelin | CJC-1295 plus Ipamorelin |
|---|---|---|
| How it works | One pathway, the GHRH signal | Two pathways, GHRH plus the ghrelin signal |
| Number of peptides | Single peptide | Two peptides blended together |
| How long it lasts | Short, roughly 10 to 20 minutes in the body | Ipamorelin is short. CJC-1295 without DAC lasts around 30 minutes. CJC-1295 with DAC can stay active 6 to 8 days |
| Typical form you stock | Single agent vial | One co-formulated blend vial |
| FDA labeling history | Was FDA approved as Geref, now compounded | No FDA approved labeling, compounding status unsettled |
| How clinics tend to describe it | The familiar, simple starting option | The layered, more complete option |
The half-life row is the one that trips people up, so let me slow down there. When a rep says CJC-1295, always ask which version. CJC-1295 without DAC, sometimes called Modified GRF 1-29, clears fast and behaves a lot like Sermorelin. CJC-1295 with DAC has a little attachment that grabs onto a protein in the blood called albumin, and that is what stretches it out to several days. Same name on the label, very different product. If an invoice just says CJC-1295 with no DAC or no-DAC note, that is an incomplete spec, and it changes both the schedule and the price. For reference, you can see how we spell it out on our CJC-1295 with Ipamorelin blend page.
The part nobody at the sales table wants to lead with
Here is where I have to be a good coordinator and not just a cheerleader for the category. If you are doing an honest CJC-1295 vs Sermorelin comparison, the regulatory picture is not the same for both, and it has been moving.
Sermorelin has a real paper trail. It carried FDA approved labeling once, and that history is why many pharmacies still feel comfortable compounding it today under the rules that govern pharmacy compounding.
CJC-1295 and Ipamorelin are a different story. Neither one has FDA approved drug labeling. Both were sitting on the FDA list of bulk drug substances used in compounding, and in September 2024 the FDA removed CJC-1295, Ipamorelin, and a few others from that list after the original sponsors withdrew their nominations. After further review, the agency signaled it was not inclined to add them to the approved list for compounding. In plain language, their status is unsettled and has been in flux. I am not saying that to scare anyone. I am saying it because if you are the clinic owner, you want to know that the ground under one of these products is firmer than the other before you build a service line on it.
So when we talk about wellness clinic peptide products, the smart move is not to assume last year’s rules still apply. Check the current status, in your state, this quarter, before you commit.

How I actually think about sourcing
Once a clinic decides a product fits, the harder work begins, and it is not clinical. It is peptide sourcing considerations. The reason I care so much about this is simple. Two vials can wear the exact same label and be completely different products inside. This is the whole reason a coordination platform exists, to connect licensed clinics with authorized pharmacies and wholesalers who can actually show their work. You can see the products we help clinics source on our injectables and peptide catalog, and our notes on what to look for in a reliable injectable supplier lay the whole vetting process out plainly.
Ask for a certificate of analysis that matches the specific lot you are buying, not a generic one from some other batch six months ago. You want to see stated purity, confirmation that the vial holds the peptide it claims, and testing for contaminants. A supplier who can hand that over without a fuss is telling you something good about how they run.
Ask about the pharmacy’s licensing and standing, plainly. Where a pharmacy compounds these products, and who does the work, is not a small detail, it is the whole thing.
Ask about consistency across orders, especially for the blend. You want the same ratio and the same quality on your tenth order that you got on your first. And ask how the product ships and how you should store it once it lands, because these are delicate peptides that do not love heat or light. The water you reconstitute with matters too, so our guide to bacteriostatic water storage and shelf life covers the questions that keep a blend stable from the loading dock all the way to the treatment room.
So which should your clinic carry?
There is no single right answer, and honestly, anyone who gives you one is selling something. Here is the calm version.
Sermorelin tends to suit clinics that want a familiar, single peptide option with a longer track record, something simple to explain at the front desk. The CJC-1295 plus Ipamorelin combination tends to appeal to clinics that want the two-pathway, more complete offering and are comfortable keeping an eye on its shifting compounding status. Plenty of clinics end up carrying both, because a patient who starts simple may later ask about the more layered option, and it is nice not to have to send them elsewhere.
Whatever you choose, the discipline is identical. The line between a clean peptide program and a messy one is rarely which growth hormone secretagogue you picked. It is whether you can stand behind the documentation, the purity, and the pharmacy behind every vial that leaves your clinic.
Frequently asked questions
What is the main difference in the CJC-1295 and Ipamorelin vs Sermorelin comparison?
Sermorelin works through one pathway, the GHRH signal. The CJC-1295 plus Ipamorelin blend works through two pathways at once, the GHRH signal and the ghrelin signal, which is why sellers offer it as one combined product. It is less about one being stronger and more about a single door versus two doors.
Is any of this FDA approved?
Sermorelin was FDA approved in the past as Geref and was later withdrawn for business reasons, and it is now supplied through compounding. CJC-1295 and Ipamorelin do not have FDA approved drug labeling, and their compounding status has been unsettled since the FDA removed them from its review list in 2024. Always confirm the current status before sourcing.
In an Ipamorelin vs Sermorelin sense, are they the same type of peptide?
No. Sermorelin is a GHRH analog, so it copies the growth hormone releasing hormone signal. Ipamorelin is a ghrelin mimetic, so it copies a different hormone entirely. That is why formulators usually pair Ipamorelin with a GHRH type peptide like CJC-1295 rather than run it on its own in these blends.
What does DAC mean on a CJC-1295 label?
DAC stands for drug affinity complex. CJC-1295 with DAC binds to a blood protein and stays active for days, while the no-DAC form clears in well under an hour. It is the single most important thing to confirm on any CJC-1295 order, since the name alone does not tell you which one you are getting.
How is this different from Somatropin?
Somatropin is growth hormone itself, delivered directly. The products in this GH peptide comparison are growth hormone secretagogues, meaning they signal the body to release its own. That is a real category difference, and it is a common point of confusion for patients doing their own peptide comparison for clinics style research online.
Disclaimer:
A quick and sincere disclaimer to close. This article is general educational information for licensed clinics and healthcare professionals thinking through their product menu. It is not medical advice, it is not a treatment recommendation, and it is not a claim that any of these products are approved for weight loss or any specific use. Regulations around compounded peptides change often. Please confirm the current FDA and state rules, rely on qualified prescribers for any clinical decision, and source only through properly licensed pharmacies and wholesalers.
Related Resources:
Growth Hormone Secretagogue Peptides: A Guide for Clinics
Tesamorelin vs. Somatropin: What Clinics Should Know
Storage and Handling Guide for Growth Hormone Secretagogue Peptides
Sourcing Growth Hormone Peptides: Purity Standards and Documentation for Clinics
Growth Hormone Secretagogue Profit Margin & ROI Guide for Clinics